PDL BioPharma, Inc. Severance Costs
PDL BioPharma, Inc. reported Severance Costs of $3.60 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2020-08-07
- PDL BioPharma, Inc. severance costs for the quarter ending 2020-06-30 was $3.60M.
- PDL BioPharma, Inc. severance costs for the quarter ending 2020-03-31 was $3.00M.
| Period end | Severance Costs 3 month | Severance Costs 6 month |
|---|---|---|
| 2020-06-30 | $3.60M 10-Q · filed 2020-08-07 | $6.60M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $3.00M 10-Q · filed 2020-05-11 |